Febuxostat Tablet
Product Images NDC 0054-0414

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Febuxostat (NDC 0054-0414). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Febuxostat Chemical Structure (Fcf23fa1 Bc2d 4cdf Bf25 51a9ee09fa0d 01)

Chemical structure of Febuxostat, showing its molecular arrangement with functional groups including a thiazole ring, a nitrile group, and an isobutoxy substituent attached to a benzene ring.*

FDA Label Image

Febuxostat-bottle-label-80-mg.jpg (Image 01)

Label for Febuxostat 40 mg oral tablets showing the proprietary name Febuxostat, strength 40 mg, and tablet dosage form. The label indicates the package contains 30 tablets. It is distributed by Hikma Pharmaceuticals USA Inc., Eatontown, NJ. Additional instructions include storage at 20° to 25°C and warnings about bottle seal integrity and light protection.*

FDA Label Image

Image 02

Label for Febuxostat 80 mg oral tablets by Hikma Pharmaceuticals USA Inc. The label states each tablet contains 80 mg of febuxostat and comes in a bottle of 30 tablets. It includes storage instructions (20° to 25°C), a barcode, and caution not to accept if the seal is broken or missing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.